ATXI — Avenue Therapeutics, Inc.
$0.2200+24.22%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ATXI in the TickerWise workspace.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 2
- Website: https://www.avenuetx.com
Latest SEC filings for ATXI
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.